| Structure | Chemical Name | CAS | MF |
|
(S)-(-)-N,N-DIMETHYL-1-FERROCENYLETHYLAMINE
|
31886-57-4
|
C14H19FeN 10*
|
|
(6S)-N6,N6-dipropyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine
|
|
|
|
Dapoxetine hydrochloride
|
129938-20-1
|
C9H7ClN2O5
|
|
(S)-(-)-N,N-DIMETHYL-1-FERROCENYLETHYLAMINE
|
54053-42-8
|
C14H19FeN 10*
|
|
(S)-N,N-dimethyl-5-oxopyrrolidine-2-carboxamide
|
63438-53-9
|
C7H12N2O2
|
|
(S)-N,N-DIETHYL-4-(PYRROLIDIN-2-YL)BENZENAMINE
|
|
C14H22N2
|
|
(S)-N,N-dibutyl-5-oxopyrrolidine-2-carboxamide
|
85551-26-4
|
C13H24N2O2
|
|
(S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine
|
132335-46-7
|
C19H21NOS
|
|
(S)-N,N-DIETHYL-4-(PIPERIDIN-2-YL)BENZENAMINE
|
1213303-31-1
|
C15H24N2
|
|
(S)-(+)-2-(N,N-DIBENZYLAMINO)-4-METHYLPENTANOL, 90%
|
111060-53-8
|
C20H27NO
|
|
(S)-N,N-DIMETHYL-1-[(R)-2-(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLAMINE
|
55650-58-3
|
C26H28FeNP 10*
|
|
(S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine
|
132335-44-5
|
C9H15NOS
|
|
(S)-(-)-N,N-DIMETHYL-1-PHENETHYLAMINE
|
17279-31-1
|
C10H15N
|
|
(6S)-N,N-dipropyl-5,6,7,8-tetrahydroindolizin-6-amine
|
140848-67-5
|
C14H24N2
|
|
(S)-N,N-diethyl-5-oxopyrrolidine-2-carboxamide
|
85760-88-9
|
C9H16N2O2
|
|
S-(N,N-DIETHYLCARBAMOYL)GLUTATHIONE SULFOXIDE
|
|
C15H26N4O8S
|
|
S-(+)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propylamide
|
116817-84-6
|
C9H15NOS
|
|
S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate
|
132335-47-8
|
C21H23NO5S
|
|
[S,(+)]-3-(N,N-Dimethylamino)-2-methylpropionic acid
|
26171-56-2
|
C6H13NO2
|
|
|
(1S)-N,N-Dibutyl-1α-methyl-5-methoxytetralin-2α-amine
|
|
|
|
|
(2S)-1-O-Decanoylglycerol
|
|
|
|
|
SODEFRIN ACETATE
|
161928-96-7
|
C48H86N12O15
|
|
|
SODEFRIN
|
|
|
|
|
SODD(SILENCEROFDEATHDOMAINS),N-TERMINAL,RABBITANTI-HUMAN,MOUSE,RAT:WB
|
|
|
|
Sodelglitazar
|
447406-78-2
|
C23H21F4NO3S2
|
|
|
SocoletButter
|
|
|
|
|
SO 3 compound
|
|
|
|
S-(N-monomethoxytritylaminoethyl)-O-(2-chlorophenyl)phosphorothioate
|
116454-97-8
|
C28H27ClNO4PS
|
|
(S)-7-[[2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-[4-methoxy-3-(phenylmethoxy)phenyl]-4H-1-benzopyran-4-one
|
94349-33-4
|
C35H40O15
|
|
(S)-7-[[6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-2-[4-methoxy-3-(phosphonooxy)phenyl]-5-(phosphonooxy)-4H-1-benzopyran-4-one, disodium salt
|
85006-16-2
|
C28H34Na2O21P2
|
|
|
(2S)-7-[[6-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2,3-dihydro-2α-[4-methoxy-3-(phosphonooxy)phenyl]-5-(phosphonooxy)-4H-1-benzopyran-4-one
|
|
|
|
|
(20S)-3β-[2-O-(6-Deoxy-β-D-glucopyranosyl)-β-D-xylopyranosyloxy]-12α,20-dihydroxy-5α-lanost-9(11)-en-18-oic acid 18,20-lactone
|
77394-03-7
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-2-(2-benzyloxycarbonylaminothiazol-4-yl)-Gly-amino]-5-cyclohexyl-2,2-difluoro-3-hydroxy-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-2-propyloxy-Gly-amino]-5-cyclohexyl-2,2-difluoro-3-hydroxy-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-L-Nle-amino]-5-cyclohexyl-2,2-difluoro-3-oxo-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-[(S)-2-amino-3-oxobutyryl]-amino]-5-cyclohexyl-2,2-difluoro-3-oxo-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-L-His-amino]-5-cyclohexyl-2,2-difluoro-3-oxo-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-Gly-amino]-5-cyclohexyl-2,2-difluoro-3-hydroxy-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-3-methoxycarbonyl-L-Ala-amino]-5-cyclohexyl-2,2-difluoro-3-oxo-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-2-propyloxy-Gly-amino]-5-cyclohexyl-2,2-difluoro-3-oxo-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-L-Thr-amino]-5-cyclohexyl-2,2-difluoro-3-hydroxy-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-3-(2-aminothiazol-4-yl)-L-Ala-amino]-5-cyclohexyl-2,2-difluoro-3-hydroxy-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-Gly-amino]-5-cyclohexyl-2,2-difluoro-3-oxo-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-L-Nle-amino]-5-cyclohexyl-2,2-difluoro-3-hydroxy-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-L-Phe-L-His-amino]-5-cyclohexyl-2,2-difluoro-3-hydroxy-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl[L-Phe-N6-[methylamino(thiocarbonyl)]-L-Lys-amino]]-5-cyclohexyl-2,2-difluoro-3-hydroxy-N-(2-morpholinoethyl)pentanamide
|
|
|
|
|
(4S)-4-[N-Morpholinosulfonyl-[L-Phe-(3-methoxycarbonyl-L-Ala-)]amino]-5-cyclohexyl-2,2-difluoro-3-hydroxy-N-(2-morpholinoethyl)pentanamide
|
|
|
|
(S)-(-)-O-DESMETHYLCARVEDILOL
|
123372-13-4
|
C23H24N2O4
|
|
S-(+)-O-DESMETHYLVENLAFAXINE
|
|
C16H25NO2
|
|
S-(+)-O-DESMETHYLVENLAFAXINE
|
142761-12-4
|
C16H25NO2
|
|
|
(2S)-1-O-β-D-Galactopyranosylglycerol
|
|
|
|
|
(4S)-3β-[2-O-(β-D-Galactopyranosyl)-β-D-glucurono pyranosyloxy]-22β-[3-O-(2-O,3-O,4-O,6-O-tetraacetyl-β-D-glucopyranosyl)-α-L-arabinopyranosyloxy]oleana-12-ene-21β,23-diol
|
|
|
|
|
SOD1 G93A protein
|
|
|
|
|
(4S)-3β-[2-O-(β-D-Galactopyranosyl)-β-D-glucurono pyranosyloxy]-22β-[3-O-(2-O,3-O,4-O-triacetyl-β-D-xylopyranosyl)-α-L-arabinopyranosyloxy]oleana-12-ene-21β,23-diol
|
|
|
|
|
SOD-4 gene product
|
|
|
|
|
SNM1 protein
|
|
|
|
|
Soc-2 protein
|
|
|
|
|
(4S)-3β-[3-O-(β-D-Glucopyranosyl)-2-O-(β-D-galactopyranosyl)-β-D-glucopyranosyloxy]-16α-hydroxy-23-oxoolean-12-en-28-oic acid 2-O-(α-L-rhamnopyranosyl)-α-L-arabinopyranosyl ester
|
|
|
|
|
(20S)-3β-[(2-O-β-D-Glucopyranosyl-β-D-glucopyranosyl)oxy]-20-[(6-O-α-L-arabinopyranosyl-β-D-glucopyranosyl)oxy]-5α-dammarane-12β,25-diol
|
|
|
|
|
(20S)-3β-[(2-O-β-D-Glucopyranosyl-β-D-glucopyranosyl)oxy]-20-[(6-O-α-L-arabinopyranosyl-β-D-glucopyranosyl)oxy]-25-hydroperoxy-5α-dammar-23-en-12β-ol
|
|
|
|
|
(20S)-3β-[(2-O-β-D-Glucopyranosyl-β-D-glucopyranosyl)oxy]-20-[(6-O-α-L-arabinopyranosyl-β-D-glucopyranosyl)oxy]-5α-dammar-23-ene-12β,25-diol
|
|
|
|
|
[S,(-)]-N,N,α,2,4,6-Hexamethylbenzenemethanamine
|
|
|
|
|
Sn3O3
|
12534-28-0
|
|
|
|
Sn4O4
|
12534-33-7
|
|
|
|
(9S)-9,11-O-[[(4-Diethylamino-1-methylbutyl)imino]methylene]-9-deoxoerythromycin
|
|
|
|
|
[S,(+)]-4-Octanol
|
|
|
|
|
(4S)-Octahydro-4aβ-hydroxy-4α,8aα-dimethyl-6α-(1-methylethenyl)-1(2H)-naphthalenone
|
97094-19-4
|
|
|
|
(S)-3-(Octadecylthio)-1,2-propanediol
|
|
|
|
|
(S)-3-(Octadecyloxy)propane-1,2-diol diacetate
|
|
|
|
|
(5S)-1,2,3,4,5,6,7,8-Octahydro-5α,8α-epoxy-2,4-dioxo-6α-(methylsulfonyl)-3-[4-(2-methoxyphenyl)piperazin-1-yl]quinazoline
|
|
|
|
|
(S)-2-Octaneol acetate
|
|
|
|
|
[[[(2S)-5α-[[(Octadecylcarbamoyl)oxy]methyl]tetrahydrofuran]-2α-yl]methyl][2-(quinolinium-1-yl)ethyl] phosphate
|
|
|
|
|
[S,(-)]-2-Octanesulfonic acid methyl ester
|
|
|
|
|
3-[[(8S)-Octahydroindolizin]-8β-yl]phenol
|
|
|
|
|
1-[2-[[(4S)-4-[(Octadecyloxy)methyl]-1,3,2-dioxaphosphorinan-2-yl]oxy]ethyl]pyridinium
|
|
|
|
|
[S,(-)]-2-Octanesulfonic acid potassium salt
|
|
|
|
|
(1S)-1,2,3,4,5,6,7,8-Octahydro-1-methyl-7β-[(R)-1-methyl-2-hydroxyethyl]-2β,3α-naphthalenediol
|
66113-29-9
|
|
|
|
[S,(-)]-2-Octanesulfonic acid
|
|
|
|
|
[S,(+)]-3-Octadecanol
|
|
|
|
|
[S,(-)]-2-Octanesulfonic acid sodium salt
|
|
|
|
|
[S,(-)]-2-Octanesulfonanilide
|
|
|
|
|
[S,(+)]-2-Octanesulfonyl chloride
|
|
|
|
|
4-[[[(S)-1,2,3,4,5,6,7,8-Octahydroisoquinolin]-1-yl]methyl]phenol
|
|
|
|
|
(3S)-1,2,3,4,5,6,7,8-Octahydro-α,α,3α,8α-tetramethyl-5α-azulenemethanol propanoate
|
|
|
|
|
[S,(+)]-2-Octadecanol
|
|
|
|
|
(S)-3-Octanol acetate
|
|
|
|
|
(1S)-1,2,3,4,5,6,7,8-Octahydro-1α-(4-methoxybenzyl)-2-methylisoquinoline
|
|
|
|
(S)-1,2-OCTADECANEDIOL
|
125555-78-4
|
C18H38O2
|
|
(S)-1,2-OCTANEDIOL
|
87720-91-0
|
C8H18O2
|
|
D(+)-2-Octanol
|
6169-06-8
|
C8H18O
|
|
(S)-(+)-3-OCTANOL
|
|
C8H18O
|
|
S-(OCTANOYL)MERCAPTOPROPYLTRIETHOXYSILANE
|
220727-26-4
|
C17H36O4SSi
|
|
(S)-(+)-(8,9,10,11,12,13,14,15-OCTAHYDRO-3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)DIMETHYLAMINE
|
389130-06-7
|
C22H26NO2P
|
|
(S)-1,2,3,4,5,6,7,8-octahydro-1-[(4-methoxyphenyl)methyl]isoquinoline
|
30356-07-1
|
C17H23NO
|
|
|
SOD, Human, Recomb.
|
|
|
|
[S]-Octahydro-indolizin-1-ol
|
197501-52-3
|
C8H15NO
|
|
(S)-(+)-3-OCTANOL
|
22658-92-0
|
C8H18O
|
|
(S)-1,2,3,4,5,6,7,8-octahydro-2,5,5-trimethyl-2-naphthol
|
670-24-6
|
C13H22O
|
|
(S)-1,2,3,4,5,6,7,8-octahydro-1-(4-methoxybenzyl)-2-methylisoquinolinium dihydrogen [R-(R*,R*)]-tartrate
|
94006-06-1
|
C26H36NO13-
|
|
(3S)-3-octanoyloxy-4-trimethylazaniumylbutanoate
|
25243-95-2
|
C15H29NO4
|